Please login to the form below

Not currently logged in
Email:
Password:

Vasella condemns ìhealthcare nationalismî

Novartis chief says governments favour local companies over multinationals

Novartis chief executive Daniel Vasella has criticised a rising trend of nationalism in the pharmaceutical sector, which he said was threatening economic efficiency, medical innovation and improved patient health.

Vasella told the Financial Times: ìWe are seeing healthcare nationalism coming back. From Japan to the US, it's all over the place.î

Recently, mergers in the sector have reflected governments' desire for national corporate champions. Ministers have shown their support for domestic industries by putting their weight behind local mergers.

Earlier this year, Germany's Bayer agreed to acquire local rival Schering AG while Novartis itself lost out in a bidding war for French firm, Aventis in 2004. In a highly politicised battle, the French government supported a rival offer from fellow French firm, Sanofi-Synthelabo.

Vasella, who is also president of the International Federation of Pharmaceutical Manufacturers and Associations, also criticised a 13 per cent price cut on hundreds of imported branded medicines imposed by the Polish government.

He said the move reflected ìgovernment pressure on multinational groups in favour of the promotion of local companiesî.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics